JLE

Dermato Mag

MENU

Aspects épidémiologiques et clinique des cancers cutanés sur peau noire. Particularités de prise en charge Volume 7, issue 1, Janvier-Février-Mars 2019

  • [1] Lyman M., Mills J.O., Shipman A.R. A dermatological questionnaire for general practitioners in England with a focus on melanoma ; misdiagnosis in black patients compared to white patients. J Eur Acad Dermatol Venereol. 2017;31:625-628. 4
  • [2] Berwick M., Weinstock M.A. Melanoma. Epidemiology trends. In: Balch C., Houghton A., Sober A., Soongs S., eds. Cutaneous melanoma. St Louis: Quality Medical publishing; 2003. 4 Edth15-23
  • [3] Swan M.C., Hudson B.A. Malignant melanoma in South Africans of mixed ancestry : a retrospective analysis. Melanoma Res. 2003;13:415-419.
  • [4] Pitche P., Nao-Koura G., Tchangai-Walla K. Epidemiology of melanoma in Togo. Int J Dermatol. 2005;44:44-45.
  • [5] Cormier J.M., Xing Y., Ding M. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006;166:1907-1914.
  • [6] Garsaud P., Boisseau-Garsaud A.M., Ossondo M. Edpidemiology of cutaneous melanoma in the West Indies (Martinique). Am J Epidemiol. 1998;147:66-68.
  • [7] Giraud R.M., Rippey E., Rippey J.J. Malignant melanoma of the skin in black Africans. S Afr Med J. 1975;49:665-668.
  • [8] Pennello G.A., Devesa S., Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev. 2000;9:291-297.
  • [9] Kosary C., Ries L., Miller B. SEER cancer statistics review, 1976e1992 : tables and graphs. Bethesda (MD): National Cancer Institute; 1995.
  • [10] Bellows C.F., Belafsky P., Fortgang I.S., Beech D.J. Melanoma in African-Americans : trends in biological behaviour and clinical characteristics over two decades. J Surg Oncol. 2001;78:10-16.
  • [11] Muchmore J.H., Mizuguchi R.S., Lee C. Malignant melanoma in American black females : an unusual distribution of primary sites. J Am Coll Surg. 1996;183:457-465.
  • [12] Diomandé M.I., Efi A.B., Hondé M., D’Horpock F., Koffi K., Boka B.M. malignant melanoma in the Ivory Coast. Epidemiologic and histology and prognosis. Study of 195 cases. Clin Exp Pathol. 1999;47:92-95.
  • [13] Hudson D.A., Krige J.E. Melanoma in black South Africans. J Am Coll Surg. 1995;180:65-71.
  • [14] Phan A., Touzet S., Dalle S., Ronger-Savlé S., Balme B., Thomas L. Acral lentiginous melanoma : a clinicoprognostic study of 126 cases. Br J Dermatol. 2006;155:561-569.
  • [15] Baubion E., Guillier A., Bolac C. Incidence et caractéristiques du mélanome en Martinique : 1996-2015. Ann Dermatol Venereol. 2017;144:S-110.
  • [16] Bolac C., Cordel N., Deschamps L., Renier M., Quist D., Derancourt C. Diagnosis of skin cancer by dermatologists in the French West Indies : a prospective study. Ann Dermatol Venereol. 2011;138:11-16. dermatologues de l’Association Martiniquaise des Dermatologues (ADERM) , Société de Dermatologie de la Guadeloupe1
  • [17] Phan A., Dalle S., Touzet S., Ronger-Savlé S., Balme B., Thomas L. Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population. Br J Dermatol. 2010;162:765-771.
  • [18] Braun R.P., Thomas L., Kolm I., French L.E., Marghoob A.A. The furrow ink test : a clue for the dermoscopic diagnosis of acral melanoma vs nevus. Arch Dermatol. 2008;144:1618-1620.
  • [19] Dawes S.M., Tsai S., Gittleman H., Barnholtz-Sloan J.S., Bordeaux J.S. Racial disparities in melanoma survival. J Am Acad Dermatol. 2016;75:983-991. 5
  • [20] Halder R.M., Bang K.M. Skin cancer in blacks in the United States. Dermatol Clin. 1988;6:397-405.
  • [21] Fleming I.D., Barnawell J.R., Burlison P.E., Runkin J.S. Skin cancer in black patients. Cancer. 1975;35:600-605.
  • [22] Munyao T.M., Othieno-Abinya N.A. Cutaneous basal cell carcinoma in Kenya. East Afr J Med. 1999;76:97-100.
  • [23] Halder R.M., Bringeman-Shah S. Skin Cancer in African Americans. Cancer. 1995;75:667-673.
  • [24] Abreo F., Sanusi D. Basal cell carcinoma in North American blacks : clinical and histopathologic study of 26 patients. J Am Acad Dermatol. 1991;25:1005-1011.
  • [25] Mora R.G., Burris R. Cancer of the skin in African Americans : a review of 128 patients with basal cell carcinoma. Cancer. 1981;47:1436-1438.
  • [26] Altman A., Rosen T., Tschen J.A., Hoffman T., Bruce S., Siegel D.M. Basal cell epithelioma in black patients. J Am Acad Dermatol. 1987;17:741-745.
  • [27] Matsuoka L.Y., Schauer P.K., Sordillo P.P. Basal cell carcinoma in black patients. J Am Acad Dermatol. 1981;4:670-672.
  • [28] Woods S.G. Basal cell carcinoma in the black population. Int J Dermatol. 1995;34:517-518.
  • [29] Laneheart W.H., Sanusi I.D., Misra R.P., O’Neal B. Metastasizing basal cell carcinoma in a stasis ulcer in a black woman. Arch Dermatol. 1983;119:587-591.
  • [30] Lambert W.C., Kaszica J., Chung H., Moore D. Metastasizing basal cell carcinoma developing in a gunshot wound in a black man. J Surg Oncol. 1984;27:97-105.
  • [31] Oram Y., Orengo I., Alford E., Green L.K., Rosen T., Netscher D.T. Basal cell carcinoma of the scalp resulting in spine mestastasis in a black patient. J Am Acad Dermatol. 1994;31:916-920.
  • [32] Scotto J, Fears TR, Kraemer KH, Fraumeni JF Jr. Non melanoma skin cancer. In : D. Schottenfeld, J.F. Fraumeni Jr. Cancer epidemiology and prevention. Ed. 2. Oxford University press, 1996 : 1313-30.
  • [33] Alam M., Ratner D. Cutaneous squamous cell carcinoma. N Eng J Med. 2001;344:975-983.
  • [32] Amir H., Mbonde M.P., Kitinya J.N. Cutaneous squamous cell carcinoma in Tanzania. Cent Afr J Med. 1992;38:439-443.
  • [33] McCall C.O., Chen S.C. Squamous cell carcinoma of the leg in African American. J Am Acad Dermatol. 2002;47:91-93.
  • [34] Rippentrop J.M., Joslyn S.A., Konety B.R. Squamous cell carcinoma of the penis : evaluation of data from Surveillance, Epidemiology, and End Results program. Cancer. 2004;101:1357-1363.
  • [35] Pitche P., Napo-Koura G., Kpodzro K., Tchangai-Walla K. Les carcinomes cutanés primitifs chez le noir africain. Retrospective de 274 cas histologiquement diagnostiqués au togo. Nouv Dermatol. 1996;15:605-606.
  • [36] Napo-Koura G., Pitche P., Tchangai-Walla K., James K., Kpodzro K. Skin cancer in Togo. Bull Cancer. 1997;84:877-879.
  • [37] Lifeso R.M., Bull C.A. Squamous cell carcinoma of the extremities. Cancer. 1985;55:2862-2867.
  • [38] Cordel N., Bonnecarrère L., Tressières B. Squamous cell carcinoma in the Afro-Caribbean community : an 11-year retrospective study. J Eur Acad Dermatol Venereol. 2017;31:1462-1467. 9
  • [39] Lazarus H.M., Herzig R.H., Bornstein R., Laipply T. Metastatic squamous cell carcinoma of the skin. JAMA. 1980;72:1196-1199.
  • [40] Rowe D.E., carol R.J., Day C.L. Jr. Prognosis factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip : implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976-990.
  • [41] Gloster H.M., Neal K. Skin cancer in skin of colour. J Am Acad Dermatol. 2006;55:741-760.
  • [42] Hinds G.A., Heald P. CTLC in skin of colour. JAAD. 2009;60:359-375.
  • [43] Criscione V.D., Weinstock M.A. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143:854-859.
  • [44] Verdonck K., Gonzales E., Van Dooren S., Vandamma A., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1 : recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7:266-281.
  • [45] Stone M.C., Styles A.R., Cockerell C.J. Hypopigmented mycosis fungoides : a report of 7 cases and review of the literature. Cutis. 2001;67:133-138.
  • [46] Rouhani P., Fletcher C.D., Devesa S.S., Toro J.R. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12144 cases. Cancer. 2008;113:616-627.